nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0781	0.147	CbGbCtD
Temsirolimus—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0781	0.147	CbGbCtD
Temsirolimus—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0696	0.131	CbGbCtD
Temsirolimus—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0655	0.124	CbGbCtD
Temsirolimus—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0442	0.0835	CbGbCtD
Temsirolimus—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0422	0.0797	CbGbCtD
Temsirolimus—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0376	0.071	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0368	0.0695	CbGbCtD
Temsirolimus—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0348	0.0657	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0221	0.0417	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0208	0.0393	CbGbCtD
Temsirolimus—MTOR—leg—chronic obstructive pulmonary disease	0.0149	0.319	CbGeAlD
Temsirolimus—MTOR—respiratory system—chronic obstructive pulmonary disease	0.00371	0.0793	CbGeAlD
Temsirolimus—FKBP1A—respiratory system—chronic obstructive pulmonary disease	0.00334	0.0713	CbGeAlD
Temsirolimus—MTOR—connective tissue—chronic obstructive pulmonary disease	0.00326	0.0698	CbGeAlD
Temsirolimus—MTOR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00299	0.0639	CbGeAlD
Temsirolimus—FKBP1A—connective tissue—chronic obstructive pulmonary disease	0.00294	0.0628	CbGeAlD
Temsirolimus—FKBP1A—bronchus—chronic obstructive pulmonary disease	0.00274	0.0587	CbGeAlD
Temsirolimus—FKBP1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00269	0.0574	CbGeAlD
Temsirolimus—FKBP1A—trachea—chronic obstructive pulmonary disease	0.00246	0.0527	CbGeAlD
Temsirolimus—MTOR—lung—chronic obstructive pulmonary disease	0.00197	0.0421	CbGeAlD
Temsirolimus—FKBP1A—lung—chronic obstructive pulmonary disease	0.00177	0.0379	CbGeAlD
Temsirolimus—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00145	0.0311	CbGeAlD
Temsirolimus—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000771	0.0165	CbGeAlD
Temsirolimus—CYP3A5—lung—chronic obstructive pulmonary disease	0.000771	0.0165	CbGeAlD
Temsirolimus—ABCB1—trachea—chronic obstructive pulmonary disease	0.00057	0.0122	CbGeAlD
Temsirolimus—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.00169	CcSEcCtD
Temsirolimus—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.00169	CcSEcCtD
Temsirolimus—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00169	CcSEcCtD
Temsirolimus—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00169	CcSEcCtD
Temsirolimus—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00169	CcSEcCtD
Temsirolimus—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00168	CcSEcCtD
Temsirolimus—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00167	CcSEcCtD
Temsirolimus—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00167	CcSEcCtD
Temsirolimus—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00167	CcSEcCtD
Temsirolimus—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00051	0.00165	CcSEcCtD
Temsirolimus—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000508	0.00164	CcSEcCtD
Temsirolimus—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000507	0.00164	CcSEcCtD
Temsirolimus—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000504	0.00163	CcSEcCtD
Temsirolimus—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00163	CcSEcCtD
Temsirolimus—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00162	CcSEcCtD
Temsirolimus—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000497	0.00161	CcSEcCtD
Temsirolimus—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00159	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.00159	CcSEcCtD
Temsirolimus—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000488	0.00158	CcSEcCtD
Temsirolimus—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00158	CcSEcCtD
Temsirolimus—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000487	0.00158	CcSEcCtD
Temsirolimus—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00157	CcSEcCtD
Temsirolimus—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000477	0.00154	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000468	0.00151	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000466	0.00151	CcSEcCtD
Temsirolimus—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.0015	CcSEcCtD
Temsirolimus—Cough—Formoterol—chronic obstructive pulmonary disease	0.000465	0.0015	CcSEcCtD
Temsirolimus—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00149	CcSEcCtD
Temsirolimus—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00149	CcSEcCtD
Temsirolimus—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00149	CcSEcCtD
Temsirolimus—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00149	CcSEcCtD
Temsirolimus—Cough—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00147	CcSEcCtD
Temsirolimus—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000456	0.00147	CcSEcCtD
Temsirolimus—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00147	CcSEcCtD
Temsirolimus—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00147	CcSEcCtD
Temsirolimus—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00147	CcSEcCtD
Temsirolimus—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00147	CcSEcCtD
Temsirolimus—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00147	CcSEcCtD
Temsirolimus—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00147	CcSEcCtD
Temsirolimus—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000453	0.00146	CcSEcCtD
Temsirolimus—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00146	CcSEcCtD
Temsirolimus—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00146	CcSEcCtD
Temsirolimus—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00146	CcSEcCtD
Temsirolimus—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00146	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.00146	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000451	0.00146	CcSEcCtD
Temsirolimus—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00144	CcSEcCtD
Temsirolimus—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00144	CcSEcCtD
Temsirolimus—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00143	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000442	0.00143	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000441	0.00143	CcSEcCtD
Temsirolimus—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00044	0.00142	CcSEcCtD
Temsirolimus—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.00142	CcSEcCtD
Temsirolimus—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00141	CcSEcCtD
Temsirolimus—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00141	CcSEcCtD
Temsirolimus—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00141	CcSEcCtD
Temsirolimus—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00141	CcSEcCtD
Temsirolimus—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00141	CcSEcCtD
Temsirolimus—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000434	0.0014	CcSEcCtD
Temsirolimus—Infection—Formoterol—chronic obstructive pulmonary disease	0.000433	0.0014	CcSEcCtD
Temsirolimus—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.0014	CcSEcCtD
Temsirolimus—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00139	CcSEcCtD
Temsirolimus—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00139	CcSEcCtD
Temsirolimus—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00139	CcSEcCtD
Temsirolimus—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00138	CcSEcCtD
Temsirolimus—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00138	CcSEcCtD
Temsirolimus—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00138	CcSEcCtD
Temsirolimus—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00138	CcSEcCtD
Temsirolimus—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00138	CcSEcCtD
Temsirolimus—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00138	CcSEcCtD
Temsirolimus—Infection—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00137	CcSEcCtD
Temsirolimus—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00137	CcSEcCtD
Temsirolimus—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00137	CcSEcCtD
Temsirolimus—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000421	0.00136	CcSEcCtD
Temsirolimus—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00135	CcSEcCtD
Temsirolimus—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00135	CcSEcCtD
Temsirolimus—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000417	0.00135	CcSEcCtD
Temsirolimus—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00135	CcSEcCtD
Temsirolimus—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00134	CcSEcCtD
Temsirolimus—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00133	CcSEcCtD
Temsirolimus—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00133	CcSEcCtD
Temsirolimus—ABCB1—lung—chronic obstructive pulmonary disease	0.00041	0.00876	CbGeAlD
Temsirolimus—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00132	CcSEcCtD
Temsirolimus—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000405	0.00131	CcSEcCtD
Temsirolimus—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.0013	CcSEcCtD
Temsirolimus—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000403	0.0013	CcSEcCtD
Temsirolimus—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000401	0.0013	CcSEcCtD
Temsirolimus—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00129	CcSEcCtD
Temsirolimus—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000397	0.00128	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000397	0.00128	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.00128	CcSEcCtD
Temsirolimus—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.00127	CcSEcCtD
Temsirolimus—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000394	0.00127	CcSEcCtD
Temsirolimus—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00127	CcSEcCtD
Temsirolimus—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000391	0.00126	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00126	CcSEcCtD
Temsirolimus—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000388	0.00125	CcSEcCtD
Temsirolimus—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.00125	CcSEcCtD
Temsirolimus—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00125	CcSEcCtD
Temsirolimus—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00125	CcSEcCtD
Temsirolimus—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00125	CcSEcCtD
Temsirolimus—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.00123	CcSEcCtD
Temsirolimus—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00123	CcSEcCtD
Temsirolimus—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000378	0.00122	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000376	0.00121	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000376	0.00121	CcSEcCtD
Temsirolimus—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00121	CcSEcCtD
Temsirolimus—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00121	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00121	CcSEcCtD
Temsirolimus—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000372	0.0012	CcSEcCtD
Temsirolimus—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.0012	CcSEcCtD
Temsirolimus—Pain—Formoterol—chronic obstructive pulmonary disease	0.000372	0.0012	CcSEcCtD
Temsirolimus—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.0012	CcSEcCtD
Temsirolimus—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.0012	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00119	CcSEcCtD
Temsirolimus—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00119	CcSEcCtD
Temsirolimus—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00118	CcSEcCtD
Temsirolimus—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00118	CcSEcCtD
Temsirolimus—Pain—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00118	CcSEcCtD
Temsirolimus—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000364	0.00118	CcSEcCtD
Temsirolimus—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00117	CcSEcCtD
Temsirolimus—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.00116	CcSEcCtD
Temsirolimus—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00116	CcSEcCtD
Temsirolimus—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00116	CcSEcCtD
Temsirolimus—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00115	CcSEcCtD
Temsirolimus—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000357	0.00115	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000356	0.00115	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000356	0.00115	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.00115	CcSEcCtD
Temsirolimus—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00115	CcSEcCtD
Temsirolimus—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00114	CcSEcCtD
Temsirolimus—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00114	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00113	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00113	CcSEcCtD
Temsirolimus—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00111	CcSEcCtD
Temsirolimus—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00111	CcSEcCtD
Temsirolimus—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00111	CcSEcCtD
Temsirolimus—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00111	CcSEcCtD
Temsirolimus—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000343	0.00111	CcSEcCtD
Temsirolimus—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.0011	CcSEcCtD
Temsirolimus—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.0011	CcSEcCtD
Temsirolimus—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00034	0.0011	CcSEcCtD
Temsirolimus—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000338	0.00109	CcSEcCtD
Temsirolimus—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00109	CcSEcCtD
Temsirolimus—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00109	CcSEcCtD
Temsirolimus—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00109	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000336	0.00109	CcSEcCtD
Temsirolimus—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00105	CcSEcCtD
Temsirolimus—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00105	CcSEcCtD
Temsirolimus—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00104	CcSEcCtD
Temsirolimus—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00104	CcSEcCtD
Temsirolimus—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.00104	CcSEcCtD
Temsirolimus—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00032	0.00103	CcSEcCtD
Temsirolimus—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00103	CcSEcCtD
Temsirolimus—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00102	CcSEcCtD
Temsirolimus—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00101	CcSEcCtD
Temsirolimus—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00101	CcSEcCtD
Temsirolimus—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000308	0.000995	CcSEcCtD
Temsirolimus—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000308	0.000995	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000994	CcSEcCtD
Temsirolimus—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000306	0.000989	CcSEcCtD
Temsirolimus—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000303	0.00098	CcSEcCtD
Temsirolimus—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000979	CcSEcCtD
Temsirolimus—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000302	0.000975	CcSEcCtD
Temsirolimus—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.000963	CcSEcCtD
Temsirolimus—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000298	0.000963	CcSEcCtD
Temsirolimus—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.000953	CcSEcCtD
Temsirolimus—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000292	0.000943	CcSEcCtD
Temsirolimus—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00094	CcSEcCtD
Temsirolimus—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.000934	CcSEcCtD
Temsirolimus—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00093	CcSEcCtD
Temsirolimus—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00093	CcSEcCtD
Temsirolimus—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000282	0.000911	CcSEcCtD
Temsirolimus—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000911	CcSEcCtD
Temsirolimus—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000909	CcSEcCtD
Temsirolimus—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.000895	CcSEcCtD
Temsirolimus—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000277	0.000895	CcSEcCtD
Temsirolimus—Rash—Formoterol—chronic obstructive pulmonary disease	0.000275	0.000887	CcSEcCtD
Temsirolimus—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.000887	CcSEcCtD
Temsirolimus—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000886	CcSEcCtD
Temsirolimus—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000886	CcSEcCtD
Temsirolimus—Headache—Formoterol—chronic obstructive pulmonary disease	0.000273	0.000881	CcSEcCtD
Temsirolimus—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.000881	CcSEcCtD
Temsirolimus—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000881	CcSEcCtD
Temsirolimus—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.000879	CcSEcCtD
Temsirolimus—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000878	CcSEcCtD
Temsirolimus—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000271	0.000876	CcSEcCtD
Temsirolimus—Rash—Montelukast—chronic obstructive pulmonary disease	0.000269	0.000869	CcSEcCtD
Temsirolimus—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000269	0.000868	CcSEcCtD
Temsirolimus—Depression—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000866	CcSEcCtD
Temsirolimus—Headache—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000863	CcSEcCtD
Temsirolimus—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.000853	CcSEcCtD
Temsirolimus—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.000845	CcSEcCtD
Temsirolimus—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000838	CcSEcCtD
Temsirolimus—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000837	CcSEcCtD
Temsirolimus—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.000836	CcSEcCtD
Temsirolimus—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000259	0.000836	CcSEcCtD
Temsirolimus—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000832	CcSEcCtD
Temsirolimus—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000253	0.000819	CcSEcCtD
Temsirolimus—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.000809	CcSEcCtD
Temsirolimus—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.000806	CcSEcCtD
Temsirolimus—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.000789	CcSEcCtD
Temsirolimus—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000766	CcSEcCtD
Temsirolimus—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000762	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000762	CcSEcCtD
Temsirolimus—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000728	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000707	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000704	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000689	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000683	CcSEcCtD
Temsirolimus—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000678	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000678	CcSEcCtD
Temsirolimus—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.000652	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000627	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00062	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000588	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000586	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000578	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000578	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000576	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000574	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000561	CcSEcCtD
Temsirolimus—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000554	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000554	CcSEcCtD
Temsirolimus—Infection—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00055	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000543	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000538	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000528	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000504	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000504	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000501	CcSEcCtD
Temsirolimus—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000152	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—LY96—chronic obstructive pulmonary disease	0.000151	0.00133	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00015	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—EGFR—chronic obstructive pulmonary disease	0.000149	0.00131	CbGpPWpGaD
Temsirolimus—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000481	CcSEcCtD
Temsirolimus—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00048	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00048	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000148	0.0013	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000148	0.0013	CbGpPWpGaD
Temsirolimus—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000477	CcSEcCtD
Temsirolimus—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000477	CcSEcCtD
Temsirolimus—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000474	CcSEcCtD
Temsirolimus—Tacrolimus—ALB—chronic obstructive pulmonary disease	0.000146	1	CrCbGaD
Temsirolimus—MTOR—Signaling by VEGF—VEGFA—chronic obstructive pulmonary disease	0.000146	0.00128	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000146	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	0.000146	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—EGFR—chronic obstructive pulmonary disease	0.000146	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—EGFR—chronic obstructive pulmonary disease	0.000144	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	0.000144	0.00126	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000143	0.00126	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000142	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—chronic obstructive pulmonary disease	0.000141	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—EGFR—chronic obstructive pulmonary disease	0.000141	0.00124	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000453	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000453	CcSEcCtD
Temsirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00122	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	0.000138	0.00121	CbGpPWpGaD
Temsirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.0012	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000136	0.00119	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000135	0.00119	CbGpPWpGaD
Temsirolimus—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000438	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000438	CcSEcCtD
Temsirolimus—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000134	0.00118	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000131	0.00115	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—chronic obstructive pulmonary disease	0.000128	0.00113	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00111	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000408	CcSEcCtD
Temsirolimus—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—IL6—chronic obstructive pulmonary disease	0.000125	0.0011	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—chronic obstructive pulmonary disease	0.000124	0.00109	CbGpPWpGaD
Temsirolimus—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000397	CcSEcCtD
Temsirolimus—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000392	CcSEcCtD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—chronic obstructive pulmonary disease	0.000121	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—chronic obstructive pulmonary disease	0.000121	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	0.000118	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000118	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000117	0.00103	CbGpPWpGaD
Temsirolimus—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000379	CcSEcCtD
Temsirolimus—FKBP1A—Disease—HDAC2—chronic obstructive pulmonary disease	0.000114	0.001	CbGpPWpGaD
Temsirolimus—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000366	CcSEcCtD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.000989	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.000111	0.000979	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000111	0.000974	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000109	0.000959	CbGpPWpGaD
Temsirolimus—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000352	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	0.000108	0.000953	CbGpPWpGaD
Temsirolimus—Rash—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000349	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000349	CcSEcCtD
Temsirolimus—Headache—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000347	CcSEcCtD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	0.000107	0.000938	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	0.000107	0.000937	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000106	0.000935	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KL—chronic obstructive pulmonary disease	0.000106	0.000931	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000106	0.000927	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000105	0.000923	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000105	0.000922	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000104	0.000917	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000104	0.00091	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	0.000104	0.000909	CbGpPWpGaD
Temsirolimus—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000329	CcSEcCtD
Temsirolimus—MTOR—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	0.000101	0.000886	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000101	0.000883	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	0.0001	0.000881	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.0001	0.00088	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.0001	0.000879	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	9.98e-05	0.000876	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	9.98e-05	0.000876	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	9.93e-05	0.000872	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.91e-05	0.00087	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	9.88e-05	0.000868	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.79e-05	0.00086	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	9.79e-05	0.00086	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	9.74e-05	0.000855	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.65e-05	0.000848	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.52e-05	0.000836	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.49e-05	0.000833	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	9.29e-05	0.000816	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	9.29e-05	0.000816	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	9.29e-05	0.000816	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	9.23e-05	0.000811	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	9.23e-05	0.000811	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	9.21e-05	0.000809	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.15e-05	0.000804	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	9.13e-05	0.000802	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	9.09e-05	0.000798	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.03e-05	0.000793	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.86e-05	0.000778	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—EGFR—chronic obstructive pulmonary disease	8.6e-05	0.000755	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.58e-05	0.000754	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	8.58e-05	0.000754	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	8.57e-05	0.000753	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	8.48e-05	0.000745	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	8.31e-05	0.00073	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.23e-05	0.000723	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	8.23e-05	0.000723	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	8.2e-05	0.00072	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.12e-05	0.000713	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	8.07e-05	0.000709	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.98e-05	0.000701	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	7.98e-05	0.000701	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ERBB3—chronic obstructive pulmonary disease	7.94e-05	0.000698	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	7.81e-05	0.000686	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	7.78e-05	0.000683	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	7.7e-05	0.000677	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	7.67e-05	0.000673	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	7.63e-05	0.00067	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.62e-05	0.000669	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—chronic obstructive pulmonary disease	7.6e-05	0.000667	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—chronic obstructive pulmonary disease	7.59e-05	0.000667	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	7.5e-05	0.000659	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.42e-05	0.000652	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	7.36e-05	0.000647	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—chronic obstructive pulmonary disease	7.28e-05	0.00064	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	7.26e-05	0.000638	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—chronic obstructive pulmonary disease	7.14e-05	0.000627	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	7.14e-05	0.000627	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	7.14e-05	0.000627	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	7.08e-05	0.000622	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	7.02e-05	0.000616	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	6.98e-05	0.000614	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.87e-05	0.000603	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR2—chronic obstructive pulmonary disease	6.87e-05	0.000603	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.86e-05	0.000602	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.85e-05	0.000602	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.77e-05	0.000595	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	6.67e-05	0.000586	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS2—chronic obstructive pulmonary disease	6.62e-05	0.000582	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KL—chronic obstructive pulmonary disease	6.46e-05	0.000567	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HDAC2—chronic obstructive pulmonary disease	6.41e-05	0.000563	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	6.33e-05	0.000556	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	6.33e-05	0.000556	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.31e-05	0.000554	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.22e-05	0.000547	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.2e-05	0.000545	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.14e-05	0.000539	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.12e-05	0.000538	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.98e-05	0.000526	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KL—chronic obstructive pulmonary disease	5.96e-05	0.000524	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.9e-05	0.000518	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	5.67e-05	0.000498	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SERPINE1—chronic obstructive pulmonary disease	5.58e-05	0.00049	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.56e-05	0.000489	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.35e-05	0.00047	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS3—chronic obstructive pulmonary disease	5.33e-05	0.000468	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—chronic obstructive pulmonary disease	5.2e-05	0.000457	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	5.19e-05	0.000456	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.18e-05	0.000455	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.04e-05	0.000443	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.03e-05	0.000442	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.98e-05	0.000438	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.98e-05	0.000437	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.88e-05	0.000428	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—chronic obstructive pulmonary disease	4.87e-05	0.000427	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ERBB3—chronic obstructive pulmonary disease	4.84e-05	0.000425	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.81e-05	0.000423	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	4.74e-05	0.000417	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.68e-05	0.000411	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4.55e-05	0.000399	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.49e-05	0.000394	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ERBB3—chronic obstructive pulmonary disease	4.47e-05	0.000392	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—chronic obstructive pulmonary disease	4.42e-05	0.000389	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.41e-05	0.000387	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—chronic obstructive pulmonary disease	4.24e-05	0.000373	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.19e-05	0.000368	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.18e-05	0.000367	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.17e-05	0.000367	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.01e-05	0.000353	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.91e-05	0.000343	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.85e-05	0.000338	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.84e-05	0.000337	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.76e-05	0.000331	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.73e-05	0.000328	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—chronic obstructive pulmonary disease	3.73e-05	0.000327	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.64e-05	0.00032	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—chronic obstructive pulmonary disease	3.61e-05	0.000317	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.6e-05	0.000316	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.59e-05	0.000315	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—chronic obstructive pulmonary disease	3.52e-05	0.000309	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.000307	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	3.47e-05	0.000305	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—chronic obstructive pulmonary disease	3.45e-05	0.000303	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.45e-05	0.000303	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.44e-05	0.000302	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.31e-05	0.000291	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.29e-05	0.000289	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.000282	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.19e-05	0.00028	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.16e-05	0.000278	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SERPINE1—chronic obstructive pulmonary disease	3.14e-05	0.000276	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.13e-05	0.000275	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.1e-05	0.000272	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.000267	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000266	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.01e-05	0.000265	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS3—chronic obstructive pulmonary disease	2.99e-05	0.000263	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.99e-05	0.000263	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.88e-05	0.000253	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.8e-05	0.000246	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—chronic obstructive pulmonary disease	2.78e-05	0.000244	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—chronic obstructive pulmonary disease	2.76e-05	0.000242	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.75e-05	0.000242	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.72e-05	0.000239	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.69e-05	0.000236	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—chronic obstructive pulmonary disease	2.65e-05	0.000233	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.59e-05	0.000228	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.56e-05	0.000225	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.53e-05	0.000222	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.49e-05	0.000219	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.48e-05	0.000218	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.47e-05	0.000217	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.42e-05	0.000212	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.41e-05	0.000212	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.34e-05	0.000205	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000204	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.000201	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000193	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.2e-05	0.000193	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.15e-05	0.000189	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—chronic obstructive pulmonary disease	2.1e-05	0.000185	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.1e-05	0.000184	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	2.07e-05	0.000182	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.03e-05	0.000178	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—chronic obstructive pulmonary disease	1.98e-05	0.000174	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.98e-05	0.000174	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—chronic obstructive pulmonary disease	1.94e-05	0.000171	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.91e-05	0.000167	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.88e-05	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.86e-05	0.000163	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000163	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.8e-05	0.000158	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.77e-05	0.000156	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.75e-05	0.000154	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000149	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.68e-05	0.000148	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000147	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.66e-05	0.000146	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.65e-05	0.000145	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—chronic obstructive pulmonary disease	1.62e-05	0.000142	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.000137	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.51e-05	0.000133	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.5e-05	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—chronic obstructive pulmonary disease	1.49e-05	0.000131	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000126	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.39e-05	0.000122	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.36e-05	0.000119	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000103	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	0.000102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.14e-05	0.0001	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.13e-05	9.92e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.08e-05	9.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	9.48e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	9.34e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.05e-05	9.18e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	8.99e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	8.94e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.95e-06	6.11e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.65e-06	5.84e-05	CbGpPWpGaD
